New Remdesivir Trial Tests Drug in Combination with Baricitinib
New patients are currently being enrolled in the University of Illinois at Chicago’s second clinical trial to study the drug remdesivir as a treatment for COVID-19.
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More
Recover your password.
A password will be e-mailed to you.
Notifications